Browsing Tag
Non-Melanoma Skin Cancer
1 post
Invion (ASX: IVX) just unlocked the door to 80% of skin cancers — here is what the data shows so far
Invion Limited (ASX: IVX) advances INV043 into basal cell carcinoma after second positive SCC data set. Read what this means for the trial and the company. →